KOAN — Apollo Biowellness Share Price
0.000.00%
Last trade - 00:00- $0.09m
- $3.59m
- $0.02m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.06 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -117.51% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | 0.03 | 0.05 | 0.02 | n/a | n/a | -56.57% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Apollo Biowellness, Inc., formerly Resonate Blends, Inc., is engaged in the discovery, development and marketing of products designed to better mankind. The Company is focused on marketing licensed patent-pending natural stem cell mobilizing agents capable of enhancing each individual's ability to mobilize their own adult stem cells from their bone marrow. The Company is also licensed under a patent-pending application to market a dual acting all-natural diet aid designed to help control hunger through normal body signals to the brain and stomach. The Company’s products are being developed for consumer and professional markets.
Directors
- Geoff Selzer CHM
- Pamela Kerwin COO
- David Thielen CIN
- Lisa Cramer CMO (51)
- Roger Babb LED (65)
- I Mosley DRC (65)
- Rajan Natarajan DRC
- John Spencer DRC (80)
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- October 30th, 2013
- Public Since
- March 31st, 1993
- No. of Shareholders
- 175
- No. of Employees
- 6
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 100,401,280
- Address
- 26565 AGOURA RD.,, SUITE 200,, CALABASAS, 91302
- Web
- Phone
- +1 5718880009
- Auditors
- Victor Mokuolu, CPA PLLC
Upcoming Events for KOAN
Q2 2025 Resonate Blends Inc Earnings Release
Similar to KOAN
Acusphere
Pink Sheets on Nasdaq
Adorbs
Pink Sheets on Nasdaq
Agentix
Pink Sheets on Nasdaq
Agrios Global Holdings
Pink Sheets on Nasdaq
Aida Pharmaceuticals
Pink Sheets on Nasdaq
FAQ
What is the Apollo Biowellness share price?
As of Today at 22:55 UTC, shares in Apollo Biowellness are trading at $0.00. This share price information is delayed by 15 minutes.
How has the Apollo Biowellness share price performed this year?
Shares in Apollo Biowellness last closed at $0.00 and the price had moved by -97.64% over the past 365 days. In terms of relative price strength the Apollo Biowellness share price has underperformed the S&P500 Index by -97.79% over the past year.
What are the analyst and broker recommendations for Apollo Biowellness?
There is no consensus recommendation for this security.
Find out moreWhat is the Apollo Biowellness dividend yield?
Apollo Biowellness does not currently pay a dividend.
Does Apollo Biowellness pay a dividend?
Apollo Biowellness does not currently pay a dividend.
When does Apollo Biowellness next pay dividends?
Apollo Biowellness does not currently pay a dividend.
How do I buy Apollo Biowellness shares?
To buy shares in Apollo Biowellness you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Apollo Biowellness?
As of the previous close price of $0.00, shares in Apollo Biowellness had a market capitalisation of $0.09m.
Where are Apollo Biowellness shares listed?
Here are the trading details for Apollo Biowellness:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: KOAN
What kind of share is Apollo Biowellness?
Based on an overall assessment of its quality, value and momentum Apollo Biowellness is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Apollo Biowellness share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Apollo Biowellness share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Apollo Biowellness. Over the past six months, its share price has underperformed the S&P500 Index by -85.46%.
As of the last closing price of $0.00, shares in Apollo Biowellness were trading -94.54% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Apollo Biowellness PE Ratio?
The Apollo Biowellness PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Apollo Biowellness?
Apollo Biowellness' management team is headed by:
- Geoff Selzer - CHM
- Pamela Kerwin - COO
- David Thielen - CIN
- Lisa Cramer - CMO
- Roger Babb - LED
- I Mosley - DRC
- Rajan Natarajan - DRC
- John Spencer - DRC